THE BASE SHELF PROSPECTUS IS ACCESSIBLE, AND THE SHELF PROSPECTUS SUPPLEMENT FOR THE PUBLIC OFFERING AND ANY AMENDMENT TO THE DOCUMENTS WILL BE ACCESSIBLE, WITHIN TWO BUSINESS DAYS, THROUGH SEDAR+
WINNIPEG, Manitoba, June 15, 2026 (GLOBE NEWSWIRE) -- Great-West Lifeco Inc. (TSX:GWO) ("Great West" or the "Corporation") announced today that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets, RBC Capital Markets, and Scotiabank pursuant to which the underwriters have agreed to purchase, on a bought deal basis, 6,000,000 Non-Cumulative First Preferred Shares, Series 24 (the "Series 24 Shares") from Great West for sale to the public at a price of C$25.00 per Series 24 Share (the "Issue Price"), representing aggregate gross proceeds of C$150 million. The Series 24 Shares will yield 5.70% per annum, payable quarterly, as and when declared by the Great West Board of Directors.
Great West has also granted the underwriters an option, exercisable up to 48 hours prior to closing, to purchase up to an additional 2,000,000 Series 24 Shares (C$50 million) at the Issue Price. Should the underwriters' option be exercised in full, the total gross proceeds of the offering will be C$200 million.
The net proceeds of the offering will be used for general corporate purposes. The offering is expected to close on or about June 22, 2026 and is subject to customary closing conditions.
Access to Offering Documents
The Series 24 Shares will be offered in Canada by way of a prospectus supplement (the "Prospectus Supplement") to Great West's short form base shelf prospectus (the "Shelf Prospectus") dated December 23, 2025. Access to the Prospectus Supplement, the Shelf Prospectus ...
